Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cann Group ( (AU:CAN) ) has provided an announcement.
Cann Group Limited has announced its Annual General Meeting scheduled for November 28, 2025, where shareholders will discuss various resolutions including financial statements, director re-elections, and capital raising initiatives. The meeting will address key corporate matters such as the approval of remuneration reports, the issuance of placement shares, and amendments to the company’s constitution, which could have significant implications for the company’s strategic direction and stakeholder engagement.
More about Cann Group
Cann Group Limited is an Australian company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The company operates research facilities and corporate headquarters in Melbourne and has a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group provides a variety of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers both domestically and internationally. Additionally, the company owns Satipharm and its patent-protected capsule technology.
Average Trading Volume: 2,690,098
Technical Sentiment Signal: Sell
Current Market Cap: A$9.85M
Learn more about CAN stock on TipRanks’ Stock Analysis page.